Skip to content
Riskpilot
← Back to search
Sign in
Get full access
XcelCyte A/S
A/S
In liquidation
Advertising protection
CVR 41466162
Søndergade 74, 8000
Aarhus C
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
1 employees
www.xcelcyte.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
XcelCyte A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
-3M
2020
-2M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-1M
-2M
-3M
-4M
-3M
2020
-2M
+33%
2021
0M
+100%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-2.628
-2.215
-78
-21
-17
Staff expenses
-237
-236
-0
-0
-0
EBITDA
-2.865
-2.451
-78
-21
-17
Depreciation & amort.
-64
-48
-0
-0
-0
EBIT
-2.930
-2.499
-78
-21
-17
Net financials
-10
-103
-80
-16
-3
Profit before tax
-2.940
-2.603
-157
-36
-19
Tax
-592
-544
-0
-0
-0
Net profit
-2.348
-2.058
-157
-36
-19
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
2.594
927
282
213
189
Equity
2.252
194
37
0
-19
Long-term debt
9
0
0
0
0
Short-term debt
333
733
245
213
207
Total debt
342
733
245
213
207
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1652600.0%
This company
2020
2024
Equity ratio
-10.0%
This company
38.2%
Market median
-126% vs market
2020
2024
Return on equity
-1925400.0%
This company
18.4%
Market median
-10464230% vs market
2020
2024
Net profit margin (of gross profit)
-1925400.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.09×
This company
2020
2024
Debt / equity
10.96×
This company
0.62×
Market median
-1668% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-06-26 – 2020-12-31
View
PDF
More on XcelCyte A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
